- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Surface Oncology is a biotechnology business based in the US. Surface Oncology shares (SURF) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.07 – the same closing value as a week prior. Surface Oncology employs 35 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Surface Oncology stock
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Surface Oncology stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SURF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Surface Oncology stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Surface Oncology stock price (NASDAQ: SURF)
Use our graph to track the performance of SURF stocks over time.Surface Oncology shares at a glance
Information last updated 2024-06-30.
| Latest market close | $1.07 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $0.95 |
| 200-day moving average | $0.82 |
| Wall St. target price | $2.38 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.66 |
Is it a good time to buy Surface Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Surface Oncology price performance over time
Historical closes compared with the close of $1.07 from 2023-09-12
| 1 week (2024-09-29) | N/A |
|---|---|
| 1 month (2024-09-06) | N/A |
| 3 months (2024-07-06) | N/A |
| 6 months (2024-04-06) | N/A |
| 1 year (2023-10-06) | N/A |
|---|---|
| 2 years (2022-10-10) | 0.94% |
| 3 years (2021-10-08) | 7.75 |
| 5 years (2019-10-10) | 1.2 |
Surface Oncology financials
| Gross profit TTM | $-37,003,000 |
|---|---|
| Return on assets TTM | -41.42% |
| Return on equity TTM | -105.78% |
| Profit margin | 0% |
| Book value | $0.81 |
| Market Capitalization | $65.7 million |
TTM: trailing 12 months
Surface Oncology share dividends
We're not expecting Surface Oncology to pay a dividend over the next 12 months.
Surface Oncology share price volatility
Over the last 12 months, Surface Oncology's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surface Oncology's is 1.7527. This would suggest that Surface Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Surface Oncology overview
Surface Oncology, Inc. , a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114.
Frequently asked questions
What percentage of Surface Oncology is owned by insiders or institutions?Currently 7.277% of Surface Oncology shares are held by insiders and 46.033% by institutions. How many people work for Surface Oncology?
Latest data suggests 35 work at Surface Oncology. When does the fiscal year end for Surface Oncology?
Surface Oncology's fiscal year ends in December. Where is Surface Oncology based?
Surface Oncology's address is: 50 Hampshire Street, Cambridge, MA, United States, 02139 What is Surface Oncology's ISIN number?
Surface Oncology's international securities identification number is: US86877M2098 What is Surface Oncology's CUSIP number?
Surface Oncology's Committee on Uniform Securities Identification Procedures number is: 86877M209
More resources on Finder
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question